Olaplex Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OLPX research report →
Range $1.4 – $2.5
Price Chart
About the company
Olaplex Holdings, Inc. is dedicated to the creation and marketing of diverse hair care solutions. Their product line includes shampoos and conditioners specifically formulated for the treatment, upkeep, and protection of hair.
- CEO
- Amanda G. Baldwin
- IPO
- 2021
- Employees
- 278
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on OLPX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.39B
- P/E
- -92.00
- Fwd P/E
- 22.19
- PEG
- 0.93
- P/S
- 3.27
- P/B
- 1.58
- EV/EBITDA
- 19.51
- Div Yield
- 0.00%
- Gross Margin
- 64.93%
- Op Margin
- -1.56%
- Net Margin
- -3.53%
- ROE
- -1.70%
- ROIC
- -0.43%
Latest fiscal year · YoY change
- Revenue
- $422.96M+0.1%
- Gross Profit
- $250.06M-14.4%
- Op Income
- $16.25M
- Net Income
- $-9,252,000-147.4%
- EPS
- $-0.01-147.1%
- OCF Growth
- -59.0%
- FCF Growth
- -59.0%
- 52W High
- $2.08
- 52W Low
- $0.99
- 50D MA
- $2.05
- 200D MA
- $1.61
- Beta
- 1.84
- RSI (14)
- 64
- Avg Volume
- 5.28M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Olaplex said 2025 sales stabilized after prior declines, with better Q4 momentum and a 2026 plan centered on hero products, innovation, and tighter execution.· March 5, 2026
- Full-year 2025 net sales were flat at $423 million; Q4 revenue rose 4.3% to $105.1 million.
- Adjusted EBITDA margin was 22.2% for the year and 12.2% in Q4, as the company kept investing in marketing and people.
- Brand work showed traction: awareness rose 7%, sentiment improved 3%, earned media value increased 14%, and the company generated about 2 billion impressions.
- Professional channel sales grew 18.9% in Q4 to $36.8 million, while DTC rose 6.6% to $43.6 million; specialty retail declined 14.5% in Q4 to $24.7 million.
- 2026 guidance calls for net sales from about -2% to +3%, adjusted gross margin of 71% to 72%, and adjusted EBITDA margin of 21% to 22%.
For full-year 2025, net sales were $423 million, flat year over year, and adjusted EBITDA margin was 22.2% versus 30.7% in the prior year. Fourth-quarter net sales were $105.1 million, up 4.3% year over year; adjusted gross margin was 70.6%, up 200 basis points; and adjusted EBITDA was $12.9 million, or 12.2% margin, versus 17.4% a year ago. Full-year adjusted gross margin was 71.8%, up 40 basis points, and adjusted EBITDA was $93.9 million. The company generated operating cash flow of $58.7 million for the year, ended with $318.7 million of cash and cash equivalents and $352.3 million of debt, and cut inventory to $60.2 million from $75.2 million in 2024. For 2026, management expects net sales of approximately -2% to +3% versus 2025, adjusted gross margin of 71% to 72%, and adjusted EBITDA margin of 21% to 22%; they said this assumes no material tariff impact and that Q1 sales and EBITDA will be below the full-year run rate because of the timing of No. 3+ investment and marketing spend.
Amanda Baldwin framed 2025 as the year Olaplex moved from planning to implementation of its ‘Bonds and Beyond’ transformation, with three priorities: generating brand demand, harnessing innovation, and executing with excellence. She said the brand relaunch, pro-channel reengagement, and innovation engine are now in place, and that December sell-through turned positive in key accounts. Her tone was constructive and confident, emphasizing that the company is entering 2026 with stronger foundations, a robust innovation pipeline, and more room to accelerate.
Catherine Dunleavy emphasized that 2025 results met or exceeded expectations across net sales, adjusted gross profit margin, and adjusted EBITDA margin, while the company built a more stabilized margin base. She highlighted Q4 adjusted gross margin of 70.6% (+200 bps), full-year adjusted gross margin of 71.8%, full-year adjusted EBITDA of $93.9 million, and operating cash flow of $58.7 million; she also noted cash of $318.7 million, debt of $352.3 million, and inventory down to $60.2 million. On 2026, she guided to 71% to 72% gross margin and 21% to 22% EBITDA margin, said Q1 EBITDA would be significantly pressured by front-loaded marketing for No. 3+, and added that the company sees the margin range as a sustainable base while maintaining an asset-light, cash-generative model.
Analysts pressed on the specialty retail versus DTC split, the cadence of 2026 sales, the strength of the pro channel, and how much of the outlook depends on international growth and new product launches. Management said retail sell-through improved sequentially in Q4 and that positive December exit trends support a better 2026, but they also acknowledged noise from the international realignment and a deliberate shift of volume toward pro partners. They explained that Q1 is lighter because 2025 had a concentrated shipment pattern for No. 4 and No. 5, while 2026 will phase in No. 3+ with heavier marketing early in the year; on pro, they pointed to the Blitz program, education, disciplined promotions, and international partner realignment as key drivers.
The call showed clear sequential improvement in sell-through, with positive December trends in key accounts, a stronger Q4, and management saying the brand relaunch is complete and now ready for execution. Olaplex also highlighted a meaningful innovation pipeline, the launch of No. 3+, and a pro-channel reset that appears to be gaining traction.
2026 guidance still implies only modest top-line growth, and management said Q1 will be meaningfully weaker because of the timing of No. 3+ and front-loaded marketing. Specialty retail remains pressured by the international realignment, Q1 EBITDA will be under pressure, and management acknowledged that the company is still in a transformation phase rather than a fully normalized growth mode.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 19.5%
- Shares Outstanding
- 672.12M
- Float Shares
- 131.30M
of shares held by institutions
141 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for OLPX, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 11.85M | ▲ 288.55K |
| Groupe La Francaise | 731.10K | ▲ 731.10K |
| Glenmede Investment Management, LP | 318.42K | ▲ 318.42K |
| California State Teachers Retirement System | 121.75K | ▼ 1.04K |
| Point72 Asia (Singapore) Pte. Ltd. | 117.91K | ▲ 117.91K |
| Two Sigma Advisers, LP | 115.80K | ▼ 333.20K |
| Janus Henderson Group PLC | 80.80K | 0 |
| Cwm, LLC | 37.99K | ▲ 23.35K |
| Cubist Systematic Strategies, LLC | 16.50K | ▲ 16.50K |
| Point72 (Difc) Ltd | 6.62K | ▲ 6.62K |
| Sunbelt Securities, Inc. | 91 | ▼ 10 |
Held by 11 ETFs
Biggest fund positions in OLPX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 7, 26 | ADVENT INTERNATIONAL, L.P. | other | 499,468,771 |
| Jul 7, 26 | MORFITT MARTHA A M | sell | 9,000 |
| Jul 7, 26 | MORFITT MARTHA A M | sell | 376,110 |
| Jul 7, 26 | Baldwin Amanda | sell | 9,129,515 |
| Jul 7, 26 | Baldwin Amanda | sell | 4,237,288 |
| Jul 7, 26 | Egan Kenneth F | sell | 10,000 |
| Jul 7, 26 | DUNLEAVY CATHERINE | sell | 3,026,885 |
| Jul 7, 26 | Duffy John C | sell | 971,384 |
| Jul 7, 26 | Duffy John C | sell | 85,000 |
| Jul 7, 26 | Duffy John C | sell | 85,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our OLPX coverage
Recent articles, reports, and earnings notes.
No research on OLPX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OLPX report →Notice of Settlement of Shareholder Derivative Actions
globenewswire.com · May 29
Compared to Estimates, Olaplex (OLPX) Q1 Earnings: A Look at Key Metrics
zacks.com · May 11
OLAPLEX Reports First Quarter 2026 Results
globenewswire.com · May 11
Olaplex Holdings, Inc. $OLPX Shares Sold by State of Alaska Department of Revenue
defenseworld.net · Apr 23
Shareholder Alert: Ademi LLP investigates whether Olaplex Holdings Inc. is obtaining a Fair Price for Public Shareholders
globenewswire.com · Apr 7
Alto Ingredients (NASDAQ:ALTO) versus Olaplex (NASDAQ:OLPX) Financial Review
defenseworld.net · Apr 5
Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX
businesswire.com · Apr 3
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Olaplex Holdings, Inc. (Nasdaq – OLPX)
globenewswire.com · Apr 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.